Free Trial
TSE:BHC

Bausch Health Companies (BHC) Stock Price, News & Analysis

Bausch Health Companies logo
C$7.41 0.00 (0.00%)
As of 05/29/2026 04:00 PM Eastern

About Bausch Health Companies Stock (TSE:BHC)

Advanced

Key Stats

Today's Range
C$7.29
C$7.48
50-Day Range
C$6.88
C$8.09
52-Week Range
C$6.06
C$11.97
Volume
916,452 shs
Average Volume
461,484 shs
Market Capitalization
C$2.77 billion
P/E Ratio
N/A
Dividend Yield
0.76%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Bausch Health Companies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

BHC MarketRank™: 

Bausch Health Companies scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Bausch Health Companies has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Bausch Health Companies has received no research coverage in the past 90 days.

  • Read more about Bausch Health Companies' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bausch Health Companies is -2.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bausch Health Companies is -2.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Bausch Health Companies has a PEG Ratio of 0.21. PEG Ratios below 1 indicate that a company could be undervalued.

  • Short Interest

    There is no current short interest data available for BHC.
  • Dividend Yield

    Bausch Health Companies has a dividend yield of 0.76%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Bausch Health Companies does not have a long track record of dividend growth.

  • Read more about Bausch Health Companies' dividend.
  • Search Interest

    13 people have searched for BHC on MarketBeat in the last 30 days. This is an increase of 160% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Bausch Health Companies to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bausch Health Companies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    11.28% of the stock of Bausch Health Companies is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    10.03% of the stock of Bausch Health Companies is held by institutions.

  • Read more about Bausch Health Companies' insider trading history.
Receive BHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BHC Stock News Headlines

Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel
See More Headlines

BHC Stock Analysis - Frequently Asked Questions

Bausch Health Companies' stock was trading at C$9.53 at the beginning of the year. Since then, BHC stock has decreased by 22.2% and is now trading at C$7.41.

Bausch Health Companies Inc. (TSE:BHC) posted its earnings results on Wednesday, April, 29th. The company reported $1.08 earnings per share (EPS) for the quarter. The business earned $3.51 billion during the quarter. Bausch Health Companies had a negative net margin of 13.54% and a positive trailing twelve-month return on equity of 120.43%.

Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Meta Platforms (META), Advanced Micro Devices (AMD), Enbridge (ENB), Shopify (SHOP), NVIDIA (NVDA) and Ford Motor (F).

Company Calendar

Last Earnings
4/29/2026
Today
6/01/2026

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
TSE:BHC
CIK
N/A
Fax
N/A
Employees
19,900
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($3.24)
Trailing P/E Ratio
N/A
Forward P/E Ratio
1.34
P/E Growth
0.21
Net Income
-C$125.65 million
Net Margins
-13.54%
Pretax Margin
N/A
Return on Equity
120.43%
Return on Assets
4.16%

Debt

Debt-to-Equity Ratio
-1,009.96
Current Ratio
1.32
Quick Ratio
0.58

Sales & Book Value

Annual Sales
C$10.53 billion
Price / Sales
0.26
Cash Flow
C$0.96 per share
Price / Cash Flow
7.76
Book Value
C($2.92) per share
Price / Book
-2.54

Miscellaneous

Outstanding Shares
373,476,000
Free Float
N/A
Market Cap
C$2.77 billion
Optionable
Not Optionable
Beta
0.63
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (TSE:BHC) was last updated on 6/1/2026 by MarketBeat.com Staff.
From Our Partners